Clinical Trial Update: Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov update reports the termination of a Phase 2 study evaluating pemetrexed with radiation for poor-risk Stage III non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (Alimta) (pemetrexed)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-04-27